Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
Holle, Julia U
Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. [electronic resource] - Annals of the rheumatic diseases Mar 2012 - 327-33 p. digital
Publication Type: Comparative Study; Journal Article
1468-2060
10.1136/ard.2011.153601 doi
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Biomarkers--blood
Blood Sedimentation
C-Reactive Protein--metabolism
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Female
Granulomatosis with Polyangiitis--diagnosis
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Recurrence
Retrospective Studies
Rituximab
Severity of Illness Index
Treatment Outcome
Young Adult
Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. [electronic resource] - Annals of the rheumatic diseases Mar 2012 - 327-33 p. digital
Publication Type: Comparative Study; Journal Article
1468-2060
10.1136/ard.2011.153601 doi
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Biomarkers--blood
Blood Sedimentation
C-Reactive Protein--metabolism
Drug Administration Schedule
Drug Evaluation
Drug Therapy, Combination
Female
Granulomatosis with Polyangiitis--diagnosis
Humans
Immunosuppressive Agents--administration & dosage
Male
Middle Aged
Recurrence
Retrospective Studies
Rituximab
Severity of Illness Index
Treatment Outcome
Young Adult